Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus? (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10620-019-05573-y

PubMed Identifier: 30847693

Publication URI: http://europepmc.org/abstract/MED/30847693

Type: Journal Article/Review

Volume: 65

Parent Publication: Digestive diseases and sciences

Issue: 2

ISSN: 0163-2116